Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

ClinicalTrials.gov ID: NCT04380142

Public ClinicalTrials.gov record NCT04380142. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study measures the efficacy, safety, and tolerability of ABBV-951 versus oral Levodopa (LD)/Carbidopa (CD) \[LD/CD\] in advanced PD participants to achieve reduction in motor fluctuations. ABBV-951 is an investigational (unapproved) drug containing Levodopa Phosphate/Carbidopa Phosphate (LDP/CDP) given subcutaneously (under the skin) for the treatment of Parkinson's Disease. Adult participants with advanced PD will be enrolled. Approximately 130 participants will be enrolled in the study in approximately 80 sites across the world. In one arm, participants will receive ABBV-951 solution as a continuous infusion under the skin plus oral placebo capsules for LD/CD. In the second arm, participants will receive placebo solution for ABBV-951 as a continuous infusion under the skin plus oral capsules containing LD/CD tablets. The treatment duration is 12 weeks. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the course of the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects, and completing questionnaires.

Study identification

NCT ID
NCT04380142
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
174 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2020 (Actual)
Primary completion
Sep 29, 2021 (Actual)
Completion
Sep 29, 2021 (Actual)
Last update posted
Nov 18, 2022

2020 – 2021

United States locations

U.S. sites
70
U.S. states
29
U.S. cities
65
Facility City State ZIP Site status
University of Alabama at Birmingham - Main /ID# 216595 Birmingham Alabama 35233 —
University of South Alabama /ID# 216757 Mobile Alabama 36604-3302 —
Xenoscience, Inc /ID# 217110 Phoenix Arizona 85004 —
Barrow Neurological Institute /ID# 216566 Phoenix Arizona 85013-4407 —
HonorHealth /ID# 216642 Phoenix Arizona 85018-2111 —
Movement Disorders Center of Arizona /ID# 216503 Scottsdale Arizona 85258-4582 —
Banner Sun Health Res Inst /ID# 216507 Sun City Arizona 85351 —
University of Arkansas for Medical Sciences /ID# 216501 Little Rock Arkansas 72205 —
The Parkinson's & Movement Disorder Institute - Fountain Valley /ID# 216705 Fountain Valley California 92708 —
Neuro Pain Medical Center /ID# 216551 Fresno California 93710-5473 —
University of California, San /ID# 216598 La Jolla California 92093 —
Loma Linda University Medical /ID# 216500 Loma Linda California 92354 —
Collaborative Neuroscience Research - Long Beach /ID# 216970 Long Beach California 90806 —
University of California, Los Angeles /ID# 216674 Los Angeles California 90095 —
SC3 Research Group - Pasadena /ID# 216821 Pasadena California 91105-3149 —
Cedars-Sinai Medical Center-West Hollywood /ID# 216561 West Hollywood California 90048 —
University of Colorado Hospital /ID# 216527 Aurora Colorado 80045 —
Alpine Clinical Research Center /ID# 216637 Boulder Colorado 80301-1880 —
Denver Neurological Research, LLC /ID# 216784 Denver Colorado 80210-7009 —
Rocky Mountain Movement Disorders Center /ID# 216737 Englewood Colorado 80113-2736 —
Christiana Care Health Service /ID# 216515 Newark Delaware 19713 —
Georgetown University Hospital /ID# 216632 Washington D.C. District of Columbia 20007 —
Parkinson's Disease and Movement Disorders Center of Boca Raton /ID# 216517 Boca Raton Florida 33486 —
Brain Matters Research /ID# 217089 Delray Beach Florida 33445 —
Fixel Institute for Neurological Diseases /ID# 216514 Gainesville Florida 32608-3928 —
Visionary Investigators Network - Miami /ID# 216679 Miami Florida 33176-2148 —
Renstar Medical Research /ID# 216765 Ocala Florida 34470 —
Neurology Associates Ormond Beach /ID# 216521 Ormond Beach Florida 32174 —
Parkinson's Disease Treatment Center of Southwest Florida /ID# 222656 Port Charlotte Florida 33980 —
University of South Florida /ID# 216638 Tampa Florida 33612 —
Premiere Research Institute - Palm Beach /ID# 217207 West Palm Beach Florida 33407-3209 —
Duplicate_Atlanta Center for Medical Res /ID# 217091 Atlanta Georgia 30331 —
The Neurological Center of North Georgia /ID# 216499 Gainesville Georgia 30501 —
Rush University Medical Center /ID# 216567 Chicago Illinois 60612 —
University of Chicago Medical /ID# 217187 Chicago Illinois 60637 —
Indiana Clinical Research Cent /ID# 216615 Indianapolis Indiana 46202 —
Univ Kansas Med Ctr /ID# 216528 Kansas City Kansas 66160 —
St Elizabeth's Medical Center - Brighton /ID# 216716 Brighton Massachusetts 02135-2907 —
Michigan State University /ID# 217158 East Lansing Michigan 48824 —
Clinical Research Professionals - Chesterfield /ID# 216669 Chesterfield Missouri 63005-1205 —
St. Luke's Hosp. of Kansas City /ID# 216633 Kansas City Missouri 64111 —
Washington University-School of Medicine /ID# 216548 St Louis Missouri 63110 —
Global Neurosciences Institute /ID# 217875 Lawrenceville New Jersey 08648-2300 —
Northwell Health /ID# 216833 Lake Success New York 11042 —
Mount Sinai Beth Israel /ID# 216712 New York New York 10003 —
University of Rochester /ID# 218737 Rochester New York 14642-0001 —
Wake Forest Univ HS /ID# 216522 Winston-Salem North Carolina 27157 —
Ohio State University - Wexner Medical Center /ID# 216900 Columbus Ohio 43210-1229 —
The Orthopedic Foundation /ID# 217157 New Albany Ohio 43054-8167 —
The Movement Disorder Clinic of Oklahoma /ID# 216860 Tulsa Oklahoma 74136-6378 —
Legacy Research Institute /ID# 216558 Portland Oregon 97232-2003 —
University of Pennsylvania /ID# 216560 Philadelphia Pennsylvania 19104-5502 —
Thomas Jefferson University Hospital /ID# 216553 Philadelphia Pennsylvania 19107 —
Prisma Health-Upstate /ID# 216594 Greenville South Carolina 29615 —
Premier Neurology, P.C. /ID# 217308 Greer South Carolina 29650 —
Coastal Neurology /ID# 217190 Port Royal South Carolina 29935-2029 —
KCA Neurology - Franklin /ID# 217419 Franklin Tennessee 37067-5914 —
Vanderbilt University Medical Center /ID# 216675 Nashville Tennessee 37232-0011 —
Houston Pulmonary Sleep and Allergy Associates /ID# 216942 Cypress Texas 77429 —
Kerwin Research Center /ID# 216587 Dallas Texas 75231-4316 —
Neurology Consultants of Dallas - LBJ Fwy /ID# 216564 Dallas Texas 75243-1188 —
Texas Movement Disorder Specialists /ID# 216523 Georgetown Texas 78628-4126 —
Houston Methodist Hospital /ID# 216707 Houston Texas 77030 —
Central Texas Neurology Consul /ID# 216629 Round Rock Texas 78681 —
University of Utah Health Care /ID# 216710 Salt Lake City Utah 84132 —
Meridian Clinical Research /ID# 216731 Norfolk Virginia 23502-3932 —
Neurological Associates - Forest Ave /ID# 216636 Richmond Virginia 23229-4913 —
Swedish Neuroscience /ID# 216526 Seattle Washington 98122-5788 —
Inland Northwest Research /ID# 221036 Spokane Washington 99202-1342 —
Medical College of Wisconsin /ID# 216498 Milwaukee Wisconsin 53226-3522 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04380142, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2022 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04380142 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →